Uroporphyrinogen III Synthase Mutations Related to Congenital Erythropoietic Porphyria Identify a Key Helix for Protein Stability

被引:27
作者
Fortian, Arola [1 ,2 ]
Castano, David [1 ]
Ortega, Gabriel [1 ]
Lain, Ana [1 ]
Pons, Miquel [2 ]
Millet, Oscar [1 ]
机构
[1] CIC bioGUNE, Struct Biol Unit, Derio 48160, Spain
[2] Inst Res Biomed, Barcelona, Spain
关键词
DIFFERENTIAL SCANNING CALORIMETRY; BONE-MARROW-TRANSPLANTATION; THERMAL-DENATURATION; KINETIC STABILITY; GENE; IDENTIFICATION; EXPRESSION; SEQUENCE; BIOSYNTHESIS; PURIFICATION;
D O I
10.1021/bi801731q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study we have investigated deleterious mutants in the uroporphyrinogen III synthase (UROIIIS) that are related to the congenital erythropoietic porphyria (CEP). The 25 missense mutants found in CEP patients have been cloned, expressed, and purified. Their enzymatic activities have been measured relative to wild-type UROIIIS activity. All mutants retain measurable activity, consistent with the recessive character of the disease. Most of the mutants with a significant decrease in activity involve residues likely associated in binding. However, other mutants are fully active, indicating that different mechanisms may contribute to enzyme missfunction. UROIIIS is a thermolabile enzyme undergoing irreversible denaturation. The unfolding kinetics of wild-type UROIIIS and the suite of mutants have been monitored by circular dichroism. This analysis allowed the identification of a helical region in the molecule, essential to retain the kinetic stability of the folded conformation. C73R is found in one-third of CEP patients, and Cys73 is part of this helix. The integrated analysis of the enzymatic activity and kinetic stability data is used to gain insight in the relationship between defects in UROIIIS sequence and CEP.
引用
收藏
页码:454 / 461
页数:8
相关论文
共 41 条
[1]   KINETICS VERSUS THERMODYNAMICS IN PROTEIN-FOLDING [J].
BAKER, D ;
AGARD, DA .
BIOCHEMISTRY, 1994, 33 (24) :7505-7509
[2]   Tetrapyrroles: the pigments of life [J].
Battersby, AR .
NATURAL PRODUCT REPORTS, 2000, 17 (06) :507-526
[3]   PROTEIN STABILITY CURVES [J].
BECKTEL, WJ ;
SCHELLMAN, JA .
BIOPOLYMERS, 1987, 26 (11) :1859-1877
[4]   Two brothers with mild congenital erythropoietic porphyria due to a novel genotype [J].
Berry, AA ;
Desnick, RJ ;
Astrin, KH ;
Shabbeer, J ;
Lucky, AW ;
Lim, HW .
ARCHIVES OF DERMATOLOGY, 2005, 141 (12) :1575-1579
[5]   Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions [J].
Bishop, DF ;
Johansson, A ;
Phelps, R ;
Shady, AA ;
Ramirez, MCM ;
Yasuda, M ;
Caro, A ;
Desnick, RJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (04) :645-658
[6]   Human uroporphyrinogen III synthase: NMR-based mapping of the active site [J].
Cunha, Luis ;
Kuti, Miklos ;
Bishop, David F. ;
Mezei, Mihaly ;
Zeng, Lei ;
Zhou, Ming-Ming ;
Desnick, Robert J. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 71 (02) :855-873
[7]  
del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO
[8]  
2-M
[9]   Congenital erythropoietic porphyria: Advances in pathogenesis and treatment [J].
Dsnick, RJ ;
Astrin, KH .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) :779-795
[10]   Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Gunther disease) [J].
Dupuis-Girod, S ;
Akkari, V ;
Ged, C ;
Galambrun, C ;
Kebaïli, K ;
Deybach, JC ;
Claudy, A ;
Geburher, L ;
Philippe, N ;
de Verneuil, H ;
Bertrand, Y .
EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (02) :104-107